Stocks
AnaptysBio (ANAB) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -95.9 | -19.4 | -55.7 | -105.3 | -143.2 | -125.6 | ||
| Changes by years, y/y, % | +59% | -80% | +188% | +89% | +36% | +18.9% | |||
AnaptysBio. EBITDA US GAAP, bln rub
AnaptysBio. EBITDA US GAAP, changes, %
AnaptysBio. EBITDA US GAAP, sum by quarters, bln rub
AnaptysBio (ANAB) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -32.3 | -36.7 | -37.0 | -35.1 | -16.8 | -125.6 | |
| Changes by years, y/y, % | +21% | +66% | -7% | +1% | -48% | |||
| Changes by quarters, q/q, % | -7% | +14% | +1% | -5% | -52% | |||
